Dr. Quay speaks with Fox News about origin of COVID-19

As we enter the new year, ongoing efforts to understand and combat COVID-19 persist, with researchers uncovering new insights into the virus’s origins.

Dr. Quay discusses recent findings regarding the initial spread of the virus, highlighting a genetic cluster identified in patients from a military hospital in Wuhan, China, suggesting transmission within a confined group.

By tracing the movement of patients to nearby subway stations and ultimately to the airport, Dr. Quay suggests Line Two of Wuhan’s subway system as a crucial transmission route. This information not only sheds light on the virus’s early spread but also aids in predicting its future mutations, guiding the development of effective therapeutics.

As debates persist regarding whether the virus originated in a seafood market or a laboratory, ongoing research aims to provide clarity in the coming months.

Read the full article on Fox News 26 Houston.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Watch Dr. Steven Quay’s interview on America at Night as he discusses genetic privacy, public health reform, and the ethics of gain-of-function research. Learn more and preorder Dr. Quay’s new book, The Code as Witness.

Dr. Steven Quay joins Real America’s Voice to explore whether President Biden’s public health changes could reflect the side effects of prostate cancer treatment. Learn how early detection and treatment can affect cognitive and physical health, and why these questions matter for both patients and national leaders.

Dr. Steven Quay joins Fox News to discuss President Biden’s advanced prostate cancer diagnosis, the importance of early detection, and what this means for patients and families. Learn more about the medical facts, treatment options, and why regular screening matters.